Nuvaring
Product Images NDC 54868-4832

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nuvaring (NDC 54868-4832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principle Display Panel (3 Ring Carton)

Packaging label for NuvaRing vaginal ring, distributed by Physicians Total Care, Inc. The label shows the product name as NUVARING VAG RING, indicates a quantity of 3 each, and includes lot number, expiration date, and manufacturer details (N.V. Organon, Oss, Netherlands). A barcode and NDC 54868-4832-1 are also visible.*

FDA Label Image

Chemical Structure (Nuvaring 01)

Chemical structure diagrams of the active ingredients Etonogestrel and Ethinyl Estradiol. The image includes the molecular formula for Etonogestrel (C22H28O2) and Ethinyl Estradiol (C20H24O2) labeled beneath their respective chemical structures.*

FDA Label Image

Figure (Nuvaring 02)

A line graph showing plasma concentrations of Etonogestrel and Ethinyl Estradiol (EE) over 21 days after insertion of NuvaRing. The x-axis represents days after NuvaRing insertion, with two y-axes: Etonogestrel concentration (pg/mL) on the left and EE concentration (pg/mL) on the right. Etonogestrel levels rise rapidly, then plateau around 1500 pg/mL, while EE levels remain relatively steady around 25 pg/mL.*

FDA Label Image

Logo (Nuvaring 03)

FDA Label Image

Logo (Nuvaring 04)

FDA Label Image

Figure (Nuvaring 05)

An instructional illustration depicting three different positions of a woman preparing for vaginal insertion: lying on her back with knees bent, squatting, and standing while resting one foot on an elevated surface. The figure is shown in simple black outlines against a gradient background.*

FDA Label Image

Figure (Nuvaring 06)

Illustration showing a hand holding the NuvaRing contraceptive vaginal ring, first by grasping it from the side and then by compressing it into a smaller, folded shape between fingers.*

FDA Label Image

Figure (Nuvaring 07)

Four-panel instructional diagram showing NuvaRing contraceptive vaginal ring placement. The top image labels female anatomy parts: uterus, vagina, and NuvaRing inserted inside the vagina. Three lower images show finger insertion to place the NuvaRing inside the vagina and the ring positioned correctly.*

FDA Label Image

Figure (Nuvaring 08)

An instructional illustration showing the insertion of NuvaRing, a vaginal contraceptive ring. The image depicts a hand holding the ring and placing it inside the vaginal canal in a side profile anatomical view.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.